The U.S. Food and Drug Administration approved the drug at the end of last year’s second quarter to treat type 2 diabetes, but analysts see a lot of potential for it in the booming market for weight-loss treatments, and doctors have already been prescribing it off-label for that.
Colleen Quinlan, the Saskatchewan Health Authority’s director of mental health and addictions, said in June that the centre will have two separate waiting rooms—one for those with mental health needs and the other for physical needs.
Diets high in saturated fat can cause neuro-inflammation responsible for depressive and anxiety disorders. The risk is increased when obesity is accompanied by metabolic dysfunctions.